Correction: In vitro drug testing using patient-derived ovarian cancer organoids

• Lin-Yu Chen,
• Yu-Ting Chou,
• Phui-Ly Liew,
• Ling-Hui Chu,
• Kuo-Chang Wen,
• Shiou-Fu Lin,
• Yu-Chun Weng,
• Hui-Chen Wang,
• Po-Hsuan Su,
• Hung-Cheng Lai

Affiliations

Lin-Yu Chen

Department of Obstetrics and Gynecology, Shuang Ho Hospital, Taipei Medical University

Yu-Ting Chou

Department of Obstetrics and Gynecology, Shuang Ho Hospital, Taipei Medical University

Phui-Ly Liew

Department of Pathology, Shuang Ho Hospital, Taipei Medical University

Ling-Hui Chu

Department of Obstetrics and Gynecology, Shuang Ho Hospital, Taipei Medical University

Kuo-Chang Wen

Department of Obstetrics and Gynecology, Shuang Ho Hospital, Taipei Medical University

Shiou-Fu Lin

Department of Pathology, Shuang Ho Hospital, Taipei Medical University

Yu-Chun Weng

Translational Epigenetics Center, Shuang Ho Hospital, Taipei Medical University

Hui-Chen Wang

Department of Obstetrics and Gynecology, School of Medicine, College of Medicine, Taipei Medical University

Po-Hsuan Su

College of Health Technology, National Taipei University of Nursing and Health Sciences

Hung-Cheng Lai

Department of Obstetrics and Gynecology, Shuang Ho Hospital, Taipei Medical University